WE ARE CANNASOUL ANALYTICS

CannaSoul Analytics is a global leader in cannabis research and development. Dedicated to developing scientific intellectual property, medical product and technologies. CannaSoul is backed by our robust scientific analysis.

Founded by world-renowned cannabis researcher Prof. Dedi Meiri from the Technion – Israel Institute of Technology, CannaSoul utilizes proprietary analytical expertise based on our accumulated clinical data and Prof. Meiri’s pioneering research. Adhering to the principles and spirit of GCLP, the company is accredited under ISO 17025 and operates under the supervision of the Israel Health Ministry’s Cannabis Unit.

technion-logo_en_black

CANNASOUL
YOUR R&D
PARTNER

PHYTO-ANALYTICS

Pioneers in the mapping of all active compounds of the cannabis plant (cannabinoids, terpenes, flavonoids). CannaSoul has partnered with some of the world’s foremost medical cannabis companies to provide access to a wide range of analytics and R&D capabilities rarely found in the industry (17025 accreditation is for 17 CNBs and 36 terpenes)

BIO–ANALYTICS

ENDOCANNABINOID
SYSTEM ANALYSIS

Well-developed analytic capabilities for Phytocannabinoids and their metabolites along with Endocannabinoids in serum, plasma, and biological tissues (PK studies)

Comprehensive analysis of the Endocannabinoid System, including availability of Endocannabinoids, prostaglandins, and cannabinoid receptors

PRE-CLINICAL &
CLINICAL STUDY

Utilizing data, technology, advanced analytics, and human expertise to help our R&D partners optimize their pre-clinical and clinical studies, with an aim toward developing scientifically proven cannabis-based medicine

EXTRACTION,
FORMULATION &
ISOLATION
TECHNOLOGIES

Proprietary knowledge of separation and isolation technologies that allow isolation of specific compounds from the cannabis plant, including the isolation of rare and minor cannabinoids

PROOF OF CONCEPT

Collaborating in planning and execution of Proof of Concept trials for cannabis-related products and technologies, including medical devices, delivery methods, and formulation

PRODUCT DEVELOPEMENT

The CannaSoul product development spectrum is centered on specific indications, using formulations that incorporate only minimal essential compounds

ANALYTICAL
ABILITIES

CannaSoul has a unique ability to map a wide variety of active compounds both in plant and biological samples. We analyze a significant percentage out of all the active compounds known in the literature.

PHYTO CANNABINOIDS 65%
TERPENES 83%
ENDOCANNABINOIDS SYSTEM’S COMPONENTS 100%